Número especial "Terapias con medicamentos para el tratamiento de la fibromialgia"
Special Issue "Drug Therapies for the Treatment of Fibromyalgia"
Dear Colleagues,
Treatment of fibromyalgia, a common, complex chronic widespread pain condition, is difficult, usually involving an empiric approach to drug therapy focused towards individual symptoms. Current medications are often limited in their effectiveness due to patients discontinuing use as a consequence of a high incidence of adverse effects. Drugs targeting a diverse range of molecular mechanisms have demonstrated modest improvement of health status in patients with fibromyalgia. Thus, the heterogeneity of fibromyalgia, suggesting existence of patient subgroups, central and peripheral aspects of the pathophysiology and a requirement of treatments targeting multiple molecular dysfunction need to be considered in the identification of new or improved therapies for the condition. Authors are invited to submit original or review articles of preclinical and clinical findings contributing to the understanding of drug therapies for the treatment of fibromyalgia.
Dr. Kim Lawson
Guest Editor
| 
